Dianthus Therapeutics, Inc. /DE/ - COM (DNTH)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
38
Total Shares
10.3M
Shares change
+83K
Total reported value, excl. options
$107M
Value change
+$519K
Put/Call ratio
0
Number of buys
17
Number of sells
-7
Price
$10.40
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.